SPL 3.06% 9.5¢ starpharma holdings limited

Great news indeed. To reduce side effects and so enable higher...

  1. 264 Posts.
    lightbulb Created with Sketch. 5
    Great news indeed. To reduce side effects and so enable higher doses of Docetaxel is a major therapeutic benefit. This reminds me of the advance Don Metcalf brought by discovering CSF in the threatment of leukaemia. Unfortunately Australia lost the patent for this discovery and the benefits went to USA . This time Starpharma and Australia will benefit!
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢
Change
-0.003(3.06%)
Mkt cap ! $39.17M
Open High Low Value Volume
10.0¢ 10.0¢ 9.5¢ $12.55K 130.3K

Buyers (Bids)

No. Vol. Price($)
4 586785 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 56840 1
View Market Depth
Last trade - 16.10pm 23/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.